HUMABIOLOGICS, INC.
Human-derived extracellular matrix, collagen, and bioinks for tissue engineering and 3D culture
- Sector
- Biotech
- Headquarters
- PHOENIX, AZ
- Founded
- 2018
- Latest Form D
- $667K, Jan 2022
- Total capital
- $692K
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $692K
- 2 Form D · last Jan 2022
- 58 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 6
- 5 pending · first 2024
- Rank in peer group#9 of 54
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$667K
- Private capital raisedForm D · SEC · 1st filing$25K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 54 peers
Line = medianBiotech · Material
- Granted patents#9 · top 17%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Mohammad AlbannaResearcherExecutive Officer, DirectorLinked by 6 patents
- Dan MahaffeyExecutive OfficerNamed in SEC Form D filings
What it has protected
USPTO · 6 granted of 11- GrantedAcellular Dermal Matrix For Skin And Surgical Reconstruction And Methods Of Making SameUSPTOUS 12,691,202
- PendingComposite Collagen Product And Method Of Making ThereofUSPTOApplication 19261395
- GrantedBone Gelatin ProcessUSPTOUS 12,415,848
Show all 11 patent records
- Acellular Dermal Matrix For Skin And Surgical Reconstruction And Methods Of Making SameJul 28, 2026 · US 12,691,202Granted
- Composite Collagen Product And Method Of Making ThereofOct 30, 2025 · Application 19261395Pending
- Bone Gelatin ProcessSep 16, 2025 · US 12,415,848Granted
- Process For Production Of A Soluble And Insoluble Collagen Product From Mammalian Dermis TissueJul 8, 2025 · US 12,351,620Granted
- Composite Collagen Product And Method Of Making ThereofJul 8, 2025 · US 12,351,621Granted
- Process For Production Of A Soluble And Insoluble Collagen Product From Mammalian Dermis TissueNov 5, 2024 · US 12,134,792Granted
- Bone Gelatin ProcessOct 1, 2024 · US 12,104,088Granted
- Bone Gelatin ProcessApplication PCTUS2025021049Pending
- Process For Production Of A Soluble And Insoluble Collagen Product From Mammalian Dermis TissueApplication PCTUS2025027610Pending
- Process For Production Of A Soluble And Insoluble Collagen Product From Mammalian Dermis TissueApplication 63463579Pending
- Bone Gelatin ProcessApplication 63454264Pending
Related companies, and why
- TBT Pharma, Inc.Similar federal contract value in Biotech · null in contracts
- Turbine Corporate Holdings, Inc.Similar federal contract value in Biotech · null in contracts
- ViCardia Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- Tychon Biosciences LLCSimilar federal contract value in Biotech · null in contracts
- Paradise Genomics, Inc.Similar federal contract value in Biotech · null in contracts
- ENGEN BIO, LLCSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .